T1	Participants 402 464	One hundred and ninety-three (193) H. pylori-positive patients
T2	Participants 1050 1145	One hundred and eighty-eight out of the 193 H. pylori-positive patients (96%) completed therapy
T3	Participants 1455 1553	Twenty-two out of the 193 enrolled subjects (11%) were not eradicated after the first-line therapy
